针对介质素-6作为腹癌的治疗方法
Neda Dadgar1, Christopher Sherry2, Jenna Zimmerman2
1Translational Hematology & Oncology Research, Enterprise Cancer Institute, Cleveland Clinic, Cleveland, OH, 44106, USA.
Journal of translational medicine
|April 30, 2024
概括
洲际蛋白-6 (IL-6) 和它的受体是腹膜癌症 (PC) 进展的关键驱动因素. 针对这种途径为PC的各种腹部癌症提供了一个有希望的新疗法策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 腹癌 (PC) 是一个重大的临床挑战,治疗选择有限.
- 在PC患者的腹腔腔中观察到高水平的互白素-6 (IL-6) 和其可溶性受体 (sIL-6-Rα).
- 越来越多地认识到IL-6途径是PC的潜在治疗标.
研究的目的:
- 提供IL-6在PC的发展和进展中的作用的全面审查.
- 阐明IL-6通路影响PC的机制.
- 探索在PC治疗中准IL-6通路的治疗潜力.
主要方法:
- 关于IL-6和PC的当前研究的文献综述.
- 对促进瘤扩散,入侵和免疫调节的机制的分析.
- 检查针对IL-6通路的治疗策略.
主要成果:
- IL-6通路有助于周瘤的扩散,中细胞的粘附和侵入,以及树皮细胞的增殖.
- IL-6调节腹腔内的免疫反应.
- 准IL-6为PC提供了一个可行的治疗途径.
结论:
- IL-6通路在腹癌的发病过程中起着至关重要的作用.
- 抑制IL-6信号传递有望治疗来自卵巢,胃,胰腺,结肠直肠,尾癌和中瘤的PC.
- 对IL-6向疗法的进一步研究是有必要的,以改善PC管理.
更多相关视频
13:37A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies
Published on: March 12, 2014
30.0K
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.3K
相关概念视频
01:27Tumor Immunotherapy
520
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
520
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
160
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
160